Common use of Access Fees From Third Parties Clause in Contracts

Access Fees From Third Parties. Biosource shall pay to TDCC [*] [*] [*] of any Technology access fees, royalties and other consideration (but excluding any volume-based royalties or other fee paid for any Products which are included in Agricultural Value-Added or Non-Agricultural Value-Added and reduced by costs as set forth hereinafter) received by Biosource from any Third Party in consideration of any permitted sublicenses of Technology Owned by TDCC licensed to Biosource pursuant to Section 3.5 and sublicensed to the Third Party. Such Technology access fees shall not be considered in determining Agricultural Value Added or Non-Agricultural Value-Added. In the event that Technology Owned by TDCC is used together with Technology Owned by Biosource or part of the consideration is non-monetary, e.g., a cross-license, the fair market value of the Technology Owned by TDCC shall be determined and used as the basis for payment to TDCC. The access fee or royalties shall be reduced by any costs of Biosource incurred in granting the rights to the Third Party prior to determining the amount to be paid to TDCC.

Appears in 1 contract

Samples: Collaboration and License Agreement (Large Scale Biology Corp)

AutoNDA by SimpleDocs

Access Fees From Third Parties. Biosource shall pay to TDCC [*] [*] [*] fifty percent (50%) of any Technology access fees, royalties and other consideration (but excluding any volume-based royalties or other fee paid for any Products which are included in Agricultural Value-Added or Non-Agricultural Value-Added and reduced by costs as set forth hereinafter) received by Biosource from any Third Party in consideration of any permitted sublicenses of Technology Owned by TDCC licensed to Biosource pursuant to Section 3.5 and sublicensed to the Third Party. Such Technology access fees shall not be considered in determining Agricultural Value Added or Non-Agricultural Value-Added. In the event that Technology Owned by TDCC is used together with Technology Owned by Biosource or part of the consideration is non-monetary, e.g., a cross-license, the fair market value of the Technology Owned by TDCC shall be determined and used as the basis for payment to TDCC. The access fee or royalties shall be reduced by any costs of Biosource incurred in granting the rights to the Third Party prior to determining the amount to be paid to TDCC.

Appears in 1 contract

Samples: Collaboration and License Agreement (Large Scale Biology Corp)

Access Fees From Third Parties. Biosource TDCC shall pay to TDCC [*] [*] [*] Biosource fifty percent (50%) of any Technology access fees, royalties and other consideration (but excluding any volume-based royalties or other fee paid for any Products which are included in Agricultural Value-Added or Non-Agricultural Value-Added and reduced by costs as set forth hereinafter) received by Biosource TDCC from any Third Party in consideration of any permitted sublicenses uses of Discovery Technology Owned by TDCC Biosource licensed to Biosource TDCC and sublicensed by TDCC to the Third Party during the Research Collaboration pursuant to Section 3.5 and sublicensed to the Third Party3.1. Such Technology access fees shall not be considered in determining Agricultural Value Added or Non-Agricultural Value-Added. In the event that Discovery Technology Owned by TDCC Biosource is used sublicensed together with Technology Owned by Biosource TDCC or DAS or part of the consideration is non-monetary, e.g., a cross-license, the fair market value of the Discovery Technology Owned by TDCC Biosource which is sublicensed shall be determined and used as the basis for payment to TDCCBiosource. The access fee fees or royalties shall be reduced by any costs of Biosource TDCC incurred in granting the rights to the Third Party prior to determining the amount to be paid to TDCCBiosource.

Appears in 1 contract

Samples: Collaboration and License Agreement (Large Scale Biology Corp)

AutoNDA by SimpleDocs

Access Fees From Third Parties. Biosource TDCC shall pay to TDCC Biosource [*] [*] ([*] ]%) of any Technology access fees, royalties and other consideration (but excluding any volume-based royalties or other fee paid for any Products which are included in Agricultural Value-Added or Non-Agricultural Value-Added and reduced by costs as set forth hereinafter) received by Biosource TDCC from any Third Party in consideration of any permitted sublicenses uses of Discovery Technology Owned by TDCC Biosource licensed to Biosource TDCC and sublicensed by TDCC to the Third Party during the Research Collaboration pursuant to Section 3.5 and sublicensed to the Third Party3.1. Such Technology access fees shall not be considered in determining Agricultural Value Added or Non-Agricultural Value-Added. In the event that Discovery Technology Owned by TDCC Biosource is used sublicensed together with Technology Owned by Biosource TDCC or DAS or part of the consideration is non-monetary, e.g., a cross-license, the fair market value of the Discovery Technology Owned by TDCC Biosource which is sublicensed shall be determined and used as the basis for payment to TDCCBiosource. The access fee fees or royalties shall be reduced by any costs of Biosource TDCC incurred in granting the rights to the Third Party prior to determining the amount to be paid to TDCCBiosource.

Appears in 1 contract

Samples: Collaboration and License Agreement (Large Scale Biology Corp)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!